肿瘤学与转化医学（英文）2016，Vol.2Issue(4)：174-178,5.DOI:10.1007/s10330-016-0145-9
Clinical significance of HBME-1, Galectin-3, and CK19 expression and the status of BRAF mutation in papillary thyroid carcinoma
Clinical significance of HBME-1, Galectin-3, and CK19 expression and the status of BRAF mutation in papillary thyroid carcinoma
Li Zheng 1Yang Zhao 1Min Zhao 1Xiangyang Hu 2Jin Huang 1Ling Ang 1Hongguang Hu 1Qiang Zou 1Jin Wang 1Mingqiang Liu1
作者信息
- 1. Department of Pathology, The Second People’s Hospital of Hefei, Hefei 230011, China
- 2. Department of Pathology, Anhui Medical University, Hefei 230032, China
- 折叠
摘要
关键词
papilary thyroid carcinoma (PTC)/human bone marrow endothelial cel markers (HBME-1)/Galectin-3/cytokeratin19 (CK19)/v-raf murine sarcoma viral oncogene homolog B1 (BRAF)Key words
papilary thyroid carcinoma (PTC)/human bone marrow endothelial cel markers (HBME-1)/Galectin-3/cytokeratin19 (CK19)/v-raf murine sarcoma viral oncogene homolog B1 (BRAF)引用本文复制引用
Li Zheng,Yang Zhao,Min Zhao,Xiangyang Hu,Jin Huang,Ling Ang,Hongguang Hu,Qiang Zou,Jin Wang,Mingqiang Liu..Clinical significance of HBME-1, Galectin-3, and CK19 expression and the status of BRAF mutation in papillary thyroid carcinoma[J].肿瘤学与转化医学（英文）,2016,2(4):174-178,5.
